advertisement
Perucho-González L 10
Showing records 1 to 10 | Display all abstracts from Perucho-González L70112 Structural and biomechanical corneal differences between patients suffering from primary congenital glaucoma and healthy volunteers
Perucho-González L
Acta Ophthalmologica 2017; 95: e107-e112
70805 Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma
Andrés-Guerrero V; Perucho-González L
Advances in Therapy 2017; 34: 378-395
70112 Structural and biomechanical corneal differences between patients suffering from primary congenital glaucoma and healthy volunteers
Sáenz-Francés F; Morales-Fernández L
Acta Ophthalmologica 2017; 95: e107-e112
70805 Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma
García-Feijoo J; Morales-Fernández L
Advances in Therapy 2017; 34: 378-395
70112 Structural and biomechanical corneal differences between patients suffering from primary congenital glaucoma and healthy volunteers
Martínez-de-la-Casa JM; Méndez-Hernández CD
Acta Ophthalmologica 2017; 95: e107-e112
70805 Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma
Saenz-Francés F; Herrero-Vanrell R
Advances in Therapy 2017; 34: 378-395
70112 Structural and biomechanical corneal differences between patients suffering from primary congenital glaucoma and healthy volunteers
Santos-Bueso E; Brookes JL
Acta Ophthalmologica 2017; 95: e107-e112
70805 Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma
Júlvez LP
Advances in Therapy 2017; 34: 378-395
70112 Structural and biomechanical corneal differences between patients suffering from primary congenital glaucoma and healthy volunteers
García-Feijoó J
Acta Ophthalmologica 2017; 95: e107-e112
70805 Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma
Llorens VP; Martínez-de-la-Casa JM; Konstas AP
Advances in Therapy 2017; 34: 378-395
